Paul TheisenPatient Acquisition
Matt TurnerPatient Affordability
David LinetskyPoint-of-Care Marketing
Matthew DurhamOmnidynamic Marketing
Bud BilanichSuccess Coach
Brenda SnowAuthentic Patient Voice
Daniel SontupeMarket Access
Liz KaneImpactful Strategy
Suma Ramadas, PhDMedical Affairs
Frank BurrellScientific Storytelling
Amy GilesIncreasing Engagement
Stacey GandlerBrand Nourishment
Pat PurcellMeeting Engagement
Joey CohenMedication Adherence
COPENHAGEN, Denmark, August 15, 2016 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today ...
Xolair® (omalizumab), indicated as add-on therapy for the treatment of chronic spontaneous urticaria (CSU)[1], ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email
